These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22644514)
1. Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma. Sudo T; Iwaya T; Nishida N; Sawada G; Takahashi Y; Ishibashi M; Shibata K; Fujita H; Shirouzu K; Mori M; Mimori K Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S324-35. PubMed ID: 22644514 [TBL] [Abstract][Full Text] [Related]
2. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma. He Z; Yi J; Jin L; Pan B; Chen L; Song H Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454 [TBL] [Abstract][Full Text] [Related]
5. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
6. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer. Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440 [TBL] [Abstract][Full Text] [Related]
7. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas. Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037 [TBL] [Abstract][Full Text] [Related]
8. Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. Niwa Y; Yamada S; Koike M; Kanda M; Fujii T; Nakayama G; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y J Surg Oncol; 2014 Nov; 110(6):764-9. PubMed ID: 24975035 [TBL] [Abstract][Full Text] [Related]
9. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma. Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103 [TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells. Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer. Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954 [TBL] [Abstract][Full Text] [Related]
12. The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients. Wen J; Luo KJ; Liu QW; Wang G; Zhang MF; Xie XY; Yang H; Fu JH; Hu Y Oncotarget; 2016 Jun; 7(25):37581-37588. PubMed ID: 27147562 [TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition (EMT) phenotype at invasion front of squamous cell carcinoma of the penis influences oncological outcomes. da Cunha IW; Souza MJ; da Costa WH; Amâncio AM; Fonseca FP; Zequi Sde C; Lopes A; Guimarães GC; Soares F Urol Oncol; 2016 Oct; 34(10):433.e19-26. PubMed ID: 27381894 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer. Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404 [TBL] [Abstract][Full Text] [Related]
16. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma. Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803 [TBL] [Abstract][Full Text] [Related]
17. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma. Yang Z; Cui Y; Ni W; Kim S; Xuan Y J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma. Li K; Wang RW; Jiang YG; Zou YB; Guo W Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694 [TBL] [Abstract][Full Text] [Related]
19. Vimentin expression is associated with decreased survival in gastric cancer. Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330 [TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis. Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]